Lyra Therapeutics Inc (LYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,968 | -15,984 | -8,547 | -93,435 | -82,456 |
| Depreciation Amortization | 359 | 255 | 128 | -1,805 | -1,689 |
| Accounts payable and accrued liabilities | -619 | -499 | -454 | -1,887 | -774 |
| Other Working Capital | -2,949 | -1,434 | -1,248 | -6,346 | -4,150 |
| Other Operating Activity | 2,384 | 2,230 | 1,279 | 33,462 | 30,410 |
| Operating Cash Flow | $-22,793 | $-15,432 | $-8,842 | $-70,011 | $-58,659 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 82,643 | 54,570 |
| PPE Investments | -2 | -2 | N/A | -2,338 | -2,396 |
| Investing Cash Flow | $-2 | $-2 | $N/A | $80,305 | $52,174 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,999 | 4,999 | N/A | 8,821 | 8,822 |
| Other Financing Activity | -726 | -358 | 0 | -290 | -290 |
| Financing Cash Flow | $4,273 | $4,641 | $N/A | $8,531 | $8,532 |
| Beginning Cash Position | 42,570 | 42,570 | 42,570 | 23,745 | 23,745 |
| End Cash Position | 24,048 | 31,777 | 33,728 | 42,570 | 25,792 |
| Net Cash Flow | $-18,522 | $-10,793 | $-8,842 | $18,825 | $2,047 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,793 | -15,432 | -8,842 | -70,011 | -58,659 |
| Capital Expenditure | -20 | -20 | N/A | -2,338 | -2,396 |
| Free Cash Flow | -22,813 | -15,452 | -8,842 | -72,349 | -61,055 |